The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322

Transplantation

Volumn 69, Issue 7, 2000, Pages 1420-1428

  Nizet, Yannick ^a   Chentoufi, Aziz Alami ^a   De La Parra, Bernardo ^a   Lewalle, Philippe ^b   Rouas, Redouane ^b   Cornet, Anne ^a   Besse, Tatianna ^b   Mourad, Michel ^b   Malaise, Jacques ^b   Squifflet, Jean Paul ^b   Bazin, Hervé ^a   Latinne, Dominique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD2 ANTIGEN; CYCLOSPORIN A; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN G2B; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BTI 322; OKT 3; STEROID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MIXED LYMPHOCYTE REACTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

EID: 0034655399     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00036     Document Type: Article

References (49)

1. Matsui K, Boniface JJ, Reay PA, Schild H, Fazekas de St Groth B, Davis, MM. Low affinity interaction of peptide-MHC complexes with T-cell receptors. Science 1991; 254: 1788.
2. Bierer BE, Burakoff SJ. T cell receptors: adhesion and signaling. Adv Cancer Res 1991; 56: 49.
3. Selvaraj P, Plunkett ML, Dustin M, Sanders ME, Shaw S, Springer TA. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature 1987; 326: 400.
4. Hahn WC, Menu E, Bothwell AL, Sims PJ, Bierer BE. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 1992; 256: 1805.
5. Sandrin MS, Mouhtouris E, Vaughan HA, Warren HS, Parish CR. CD48 is a low affinity ligand for human CD2. J Immunol 1993; 151: 4606.
6. Bell GM, Fargnoli J, Bolen JB, Kish L, Imboden JB. The SH3 domain of p56(lck) binds to proline-rich sequences in the cytoplasmic domain of CD2. J Exp Med 1996; 183: 169.
7. Shimizu Y, Mobley JL, Finkelstein LD, Chan AS. A role for phosphatidylinositol 3-kinase in the regulation of beta 1 integrin activity by the CD2 antigen. J Cell Biol 1995; 131: 1867.
8. Samstag Y, Eckerskorn C, Wesselborg S, Henning S, Wallich R, Meuer SC. Costimulatory signals for human T-cell activation induce nuclear translocation of pp19/cofilin. Proc Natl Acad Sci USA 1994; 91: 4494.
9. Meuer SC, Hussey RE, Fabbi M, et al. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 1984; 36: 897.
10. Martin PJ, Longton G, Ledbetter JA, et al. Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. J Immunol 1983; 131: 180.
11. Tadmori W, Reed JC, Nowell PC, Kamoun M. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies. J Immunol 1985; 134: 1709.
12. Van Wauwe J, Goossens J, Decock W, Kung P, Goldstein G. Suppression of human T-cell mitogenesis and E-rosette formation by the monoclonal antibody OKT11A. Immunology 1981; 44: 865.
13. Guckel B, Berek C, Lutz M, Altevogt P, Schirrmacher V, Kyewski BA. Anti CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med 1991; 174: 957.
14. Lin J, Yon RW, Chavin KD, et al. Anti CD2 monoclonal antibody-induced receptor changes: Down-modulation of cell surface CD2. Transplantation 1995; 59: 1162.
15. Fortner KA, Russell JQ, Budd RC. Down-modulation of CD2 delays deletion of superantigen-responsive T cells. Eur J Immunol 1998; 28: 70.
16. Sido B, Dengler TJ, Otto G, Zimmermann R, Muller P, Meuer SC. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production. Eur J Immunol 1998; 28: 1347.
17. Ohno H, Ushiyama C, Taniguchi M, Germain RN, Saito T. CD2 can mediate TCR/CD3-independent T cell activation. J Immunol 1991; 146: 3742.
18. Mollereau B, Blanchard D, Deas O, et al. Relationship between proliferation and susceptibility to CD95-and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis. J Immunol 1997; 159: 2668.
19. Mollereau B, Deckert M, Deas O, et al. CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation. J Immunol 1996; 156: 3184.
20. Kozarsky KF, Tsai C, Bott CM, Allada G, Li LL, Fox DA. An anti-CD2 monoclonal antibody that both inhibits and stimulates T cell activation recognizes a subregion of CD2 distinct from known ligand-binding sites. Cell Immunol 1993; 150: 235.
21. + human T cells in vitro. Int Immunol 1996; 8: 1113.
22. Dumont C, Deas O, Mollereau B. Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells. J Immunol 1998; 160: 3797.
23. Mourad M, Besse T, Malaise J, et al. BTI-322 for acute rejection after renal transplantation. Transplant Proc 1997; 29: 2353.
24. Falkoff RM, Peters M, Fauci AS. T cell enrichment and depletion of human peripheral blood mononuclear cell preparations: unexpected findings in the study of the functional activities of the separated populations. J Immunol Methods 1982; 50: 39.
25. van Vugt MJ, Heijnen AF, Capel PJ. FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo. Blood 1996; 87: 3593.
26. Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Methods 1996; 196; 137.
27. Kaplan ME, Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods 1974; 5: 131.
28. fyn molecular complex (p85) and a novel CD3/Ti-associated (pp29/30) dimer. In: Schlossman SF, Boumsell W, Gilks, et al., eds. Leukocyte typing V. Oxford, Oxford University Press, 1995: 350.
29. Hale G, Clark M, Waldmann H. Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes. J Immunol 1985; 134: 3056.
30. Shen L, Guyre PM, Ball ED, Fanger MW. Glucorticoid enhances gamma interferon effects on human monocytes antigen expression and ADCC. Clin Exp Immunol 1986; 65Ñ: 387.
31. Majeau GR, Meier W, Jimmo B, Kioussis D, Hochman PS. Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins: inhibition of T cell responses. J Immunol 1994; 152: 2753.
32. Schroff RW, Klein RA, Farrell MM, Stevenson HC. Enhancing effects of monocytes on modulation of a lymphocyte membrane antigen. J Immunol 1984; 133: 2270.
33. Wesselborg S, Prufer U, Wild M, Schraven B, Meuer SC, Kabelitz D. Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 1993; 23: 2707.
34. Rouleau M, Bernard A, Vernant JP, Charpentier B, Senik A. Apoptosis of CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb. J Immunol 1993; 151: 3547.
35. Rouleau M, Mollereau B, Bernard A, et al. Mitogenic CD2 monoclonal antibody pairs predispose peripheral T cells to undergo apoptosis upon interaction with a third CD2 monoclonal antibody. J Immunol 1994; 152: 4861.
36. Van de Winkel JG, Capel PJ. General characteristics of human IgG Fc receptors. In: van de Winkel JG, Capel PJ, eds. Human IgG Fc Receptors. MBIU, R.G. Landes Company, Springer Verlag, 1996; 227.
37. Bruggemann M, Teale C, Clark , Bindon C, Waldmann H : A matched set of rat/mouse chimeric antibodies: identification and biological properties of rat H chain constant region μ, γ1l, γ2a, γ2b, γ2c, ∈ and α. J Immunol 1989; 142: 3145.
38. Chassoux DM, Linares-Cruz LG, Bazin H, Stanislawski M. K-cell-mediated cytotoxicity induced with rat monoclonal antibodies. I. Antibodies of various isotypes differ in their ability to induce cytotoxicity mediated by rat and human effectors. Immunology 1988; 65: 623.
39. Sayre PH, Chang HC, Hussey RE. Molecular cloning and expression of T11 cDNAs reveal a receptor like structure on human T lymphocytes. Proc Natl Acad Sci USA 1987; 84: 2941.
40. Domzig W, Stadler BM, Herberman RB. Interleukin 2 dependence of human natural killer cell activity. J Immunol 1983; 130: 170.
41. Van de Winkel JG, Boonen JC, Janssen PL, Vlug A, Hogg N, WJ Tax. Activity of two types of Fc receptors, FcγRI and FcγRII, in human monocyte cytotoxicity to sensitized erythrocytes. Scand J Immunol 1989; 29: 23.
42. Martin JHJ, Edwards SW. Changes in mechanisms of monocyte/ macrophage mediated cytotoxicity during culture. J Immunol 1993; 150: 3478.
43. Thomas R, Davis LS, Lipsky PE. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J Immunol 1993; 151: 6840.
44. King PD, Katz DR. Human tonsillar dendritic cell-induced T cell responses: analysis of molecular mechanisms using monoclonal antibodies. Eur J Immunol 1989; 19: 581.
45. Prickett TC, McKenzie JL, Hart NJ. Adhesion molecules on human tonsil dendritic cells. Transplantation 1992; 53: 483.
46. Nishioka WK, Welsh RM. Susceptibility to cytotoxic T lymphocyte induced apoptosis is a function of the proliferative status of the target. J Exp Med 1994; 179: 769.
47. Ceuppens JL, Baroja ML, Van Vaeck F, Anderson CL. Defect in the membrane expression of high affinity 72-kD Fc gamma receptors on phagocytic cells in four healthy subjects. J Clin Invest 1988; 82: 571.
48. Halvorsen R, Leivestad T, Gaudernack G, Thorsby E. Accessory cell-dependent T-cell activation via Ti-CD3: involvement of CD2-LFA-3 interactions. Scand J Immunol 1988; 28: 277.
49. van Seventer GA, Shimizu Y, Horgan KJ, Luce GE, Webb D, Shaw S. Remote T cell co-stimulation via LFA-1/ICAm-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. Eur J Immunol 1991; 21: 1711.